Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Faron Pharmaceuticals Oy (LSE:FARN) — Small-Cap FTSE AIM All-Share Stock Watch: The Catalyst Investors Are Tracking Now

Faron Pharmaceuticals is being watched for clinical development progress, financing capacity and regulatory milestones around its oncology pipeline. Attention is on trial data, patient recruitment, partner interest, cash runway and the ability to advance lead programmes while controlling development costs.

Ankur Sharma | 12 November 2026

Kooth (LSE:KOO) — Small-Cap FTSE AIM All-Share Market Spotlight: What Is Driving Attention Today

Kooth is being watched as investors assessDemandfor digital mental-health services, contract wins and the scalability of its technology platform. Attention is on public-sector funding, US and UK opportunities, user engagement,Revenuegrowth, cash generation and the conversion of partnerships into longer-term contracts.

Ankur Sharma | 12 November 2026

Shield Therapeutics (LSE:STX) — Small-Cap FTSE AIM All-Share Stock Watch: The Catalyst Investors Are Tracking Now

Shield Therapeutics is in focus following its Q3 update showing continued growth in commercial prescriptions and US ACCRUFeR revenue, alongside the strategic shift to full US commercial control from 1 October. The company now expects a single-digit million-dollar operating loss for 2026 because of …

Ankur Sharma | 12 November 2026

Time To ACT (LSE:TTA) — Small-Cap FTSE AIM All-Share Market Spotlight: What Is Driving Attention Today

Time To ACT is being watched as investors assess progress in its healthcare and life-science strategy, funding requirements and commercialisation milestones. Attention is on programme development, partnerships, cash runway and the ability to convert intellectual property or platform capabilities into measurable commercial value.

Ankur Sharma | 12 November 2026

Why Did Venture Life Group Plc LSE:VLG Fall 1.43% Despite a Firmer London Session?

Venture Life Group Plc — LSE:VLG closed 1.43% lower on12 November 2026, with the shares at 69.00p after a decrease of 1.00p on the day.

Ishan Mudgal | 12 November 2026

Why Did Anpario Plc LSE:ANP Fall 1.91% Despite a Firmer London Session?

Anpario Plc — LSE:ANP closed 1.91% lower on12 November 2026, with the shares at 514.00p after a decrease of 10.00p on the day.

Ishan Mudgal | 12 November 2026

Worldwide Healthcare Trust (LSE:WWH): What Is Driving Interest in Global Healthcare Investing?

Worldwide Healthcare Trust shares rose 0.61% to around 409.0p on 12 Nov 2026, a gain of 2.50p, based on market data.

Divya Sood | 12 November 2026

Convatec (LSE:CTEC): Chronic Care Franchises and a Buyback Define the Second Half

Convatec Group Plc (LSE:CTEC) shares rose 0.87% to 255.6p today, a gain of 2.2p. The medical products company remains in focus following its half-year results to 30 June 2026, which included a higherInterim Dividendand a new buyback.

Ankur Sharma | 12 November 2026

OXB (LSE:OXB): How Does a Cell and Gene Therapy Manufacturer Plan Its Growth?

OXB plc shares fell 1.08% to around 549.0p on 12 Nov 2026, a decline of 6.00p, based on market data.

Divya Sood | 12 November 2026

AstraZeneca (LSE:AZN): Oncology Momentum and a Deep Late-Stage Pipeline Under the Spotlight

AstraZeneca Plc (LSE:AZN) shares rose 0.99% to 14,034.0p today, a gain of 138.0p. The pharmaceutical group is the largest company by weighting in the FTSE 100 at 8.10%, and it remains in focus following its third-quarter results.

Ankur Sharma | 12 November 2026
Support

Hi! How can we help you today?

Loading…